Your browser doesn't support javascript.
loading
Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja, Ankit; Kumar, Robin; Singh, Amarinder; Dhar Dubey, Ravindra; Mintoo, Mubashir J; Singh, Gurdarshan; Mondhe, Dilip M; Panda, Amulya K; Gupta, Prem N.
Afiliação
  • Saneja A; Formulation & Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India; Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi, India.
  • Kumar R; Product Development Cell-II, National Institute of Immunology, New Delhi, India.
  • Singh A; PK-PD-Toxicoloy Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
  • Dhar Dubey R; Formulation & Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
  • Mintoo MJ; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
  • Singh G; PK-PD-Toxicoloy Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India; Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi, India.
  • Mondhe DM; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India; Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi, India. Electronic address: dmmondhe@iiim.ac.in.
  • Panda AK; Product Development Cell-II, National Institute of Immunology, New Delhi, India. Electronic address: amulya@iiim.res.in.
  • Gupta PN; Formulation & Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India; Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi, India. Electronic address: pngupta@iiim.ac.in.
Int J Pharm ; 531(1): 153-166, 2017 Oct 05.
Article em En | MEDLINE | ID: mdl-28823888
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triterpenos / Portadores de Fármacos / Carcinoma de Ehrlich / Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triterpenos / Portadores de Fármacos / Carcinoma de Ehrlich / Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article